The Alzheimer’s Drug Discovery Foundation considers financial assistance for relevant grant applications that were submitted to the National Institute on Aging (NIA) or the National Institute of Neurological Disorders and Stroke (NINDS) and were scored but not funded. Proposals that fall within the ADDF’s current funding priorities for drug discovery, clinical trials, biomarkers, and prevention will be considered.
Receiving interim funding by the Foundation will enable investigators to continue valuable research projects and obtain additional preliminary data to aid in future funding efforts.
Funding & Duration
- Average Duration: Varies (multi-year)
- Average Award: Varies
Non-domestic (non-US) Entities (Foreign Institutions) are eligible to apply.
Please review the relevant Request for Proposals for a list of current funding priorities:
- Rolling deadline – applications may be submitted for internal review at any time
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review